bioRxiv · 10.1101/2023.10.03.560654
Engineering of Salmonella phages into novel antimicrobial Tailocins
Abstract
Due to the extensive use of antibiotics, the increase of infections caused by antibiotic resistant bacteria are now a global health concern. Phages have proven useful for treating bacterial infections and represent a promising alternative or complement to antibiotic treatment. Yet, other alternative exists, such as bacteria-produced non-replicative protein complexes that can kill their targeted bacteria by puncturing their membrane (Tailocins). To expand the repertoire of Tailocins available, we suggest a new approach transforming phages into Tailocins. Here we genetically engineered the virulent Ackermannviridae phage S117, as well as temperate phages Fels-1, -2 and Gifsy-1 and -2 targeting the food pathogen Salmonella, by deleting the portal vertex or major capsid gene using CRISPR-Cas9. We report the production of Tailocin particles from engineered virulent and temperate phages able to kill their native host. Our work represents a steppingstone to tape into the huge diversity of phages and transform them into versatile puncturing new antimicrobials.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Woudstra, C., Sorensen, A. N., Brondsted, L.. 2023-10-03. Engineering of Salmonella phages into novel antimicrobial Tailocins. https://doi.org/10.1101/2023.10.03.560654
Cite the original work for its findings. Save a collection to share your selection of sources.